Delivery Order SPE2DB22D3004-SPE2DB25FRW85
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for $5,099.64 to supply 4,565,322,689 units of Ceftriaxone 2 GM-D5W bags. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ceftriaxone 2 GM-D5W bags with a ceiling value of $7,765.88. This non-competitive delivery order, issued on September 9, 2025, represents a firm fixed-price pharmaceutical procurement supporting federal medical supply requirements. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, a commonly used broad-spectrum antibiotic. The contract, valued at $5,210.50 with a firm fixed-price structure, is scheduled for completion by June 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ceftriaxone 1 GM-D5W bags, with a contract value of $4,118.65. This delivery order represents a firm fixed price procurement with an ultimate completion date of September 18, 2025, and utilizes no set-aside provisions, indicating competitive award procedures. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ceftriaxone 1 GM-D5W bags, a commonly used antibiotic medication, with a ceiling value of $4,818.16. The award, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, a common antibiotic medication used across military and federal healthcare systems. This competitively awarded, non-set-aside delivery order carries a ceiling value of $8,086.70 under firm fixed pricing, with an ultimate completion date of August 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,548.17 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 1 GM-D5W bags, a broad-spectrum antibiotic used in military and federal healthcare settings. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement practices. The award was issued on August 18, 2025, with an ultimate completion date of August 19, 2025, and the product will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Ceftriaxone 1 GM-D5W bags, a common broad-spectrum antibiotic used extensively in military and federal healthcare systems. This firm fixed price delivery order, valued at $9,528.22, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ceftriaxone 1 GM-D5W bags valued at $1,234.64 under a firm fixed-price contract type. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $9,224.08 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, an antibiotic medication commonly used in military and federal healthcare systems. The contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. Performance will be completed by August 13, 2025, with the product supplied from AmerisourceBergen's location in Conshohocken,...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRW85Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 2 GM-D5W bags, a commonly used intravenous antibiotic, with a ceiling value of $4,008.37. The contract was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, under a firm fixed price arrangement with no set-aside designation. Performance will be conducted at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. As the prime contractor under this comprehensive pharmaceutical supply vehicle, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying pharmaceutical products and medical supplies to military and veteran healthcare systems worldwide. The IDC enables DLA to procure a broad range of generic and brand-name medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Department of Defense healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 8/7/25 |